Regulatory

Regulatory  ·  Weekly Digest 03 May to 09 May 2025
Adcentrx Therapeutics granted Fast Track Designation for ADRX-0706 nectin-4 ADC for the treatment of advanced cervical cancer

Weekly Digest – May 2025 Weekly Digest – May 2025 06 May 2025: Adcentrx Therapeutics granted Fast Track Designation for ADRX-0706 nectin-4 ADC for the treatment of advanced cervical cancer Adcentrx Therapeutics received FDA Fast Track designation for its lead […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 03 May to 09 May 2025
IDEAYA Biosciences announces US FDA IND-clearance for IDE849, a potential first-in-class DLL3 TOP1 ADC, for a Phase 1 study in solid tumors

Weekly Digest – May 2025 Weekly Digest – May 2025 06 May 2025: IDEAYA Biosciences announces US FDA IND-clearance for IDE849, a potential first-in-class DLL3 TOP1 ADC, for a Phase 1 study in solid tumors IDEAYA Biosciences received FDA clearance […]

by Sandhya Ramalingam

Continue Reading